Exhibit 10.1          


PLACEMENT AGENCY AGREEMENT


 


March 2, 2012


 


CONFIDENTIAL


 


Sunrise Securities Corp.


600 Lexington Avenue, 23rd Floor


New York, NY 10022


 


Ladies and Gentlemen:


 


LiqTech International, Inc., a Nevada
corporation (the “Company”), proposes to issue and sell registered securities of the Company, consisting
of up to 8,333,333 shares of Common Stock (the “Shares” or the “Securities”).
“Common Stock” means the Company’s common stock, $0.001 par value per share.


 


Subject to the terms of this Placement
Agency Agreement (the “Agreement”), Sunrise Securities Corp. (“Sunrise” or
the “Placement Agent”) shall serve as the exclusive placement agent for the Company, on a “best
efforts” basis, in connection with the proposed offering of the Securities (the “Placement”). The
terms of such Placement shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser”
and collectively, the “Purchasers”) and nothing herein constitutes that the Placement Agent would have
the power or authority to bind the Company or any Purchaser or creates an obligation for the Company to issue any Securities or
complete the Placement. This Agreement and the documents executed and delivered by the Company to the Purchasers in connection
with the Placement shall be collectively referred to herein as the “Transaction Documents.”


 


The Company expressly acknowledges and
agrees that the Placement Agent’s obligations hereunder are on a best efforts basis only and that the execution of this Agreement
does not constitute a commitment by the Placement Agent to purchase any of the Securities and does not ensure the successful placement
of the Securities or any portion thereof, or the success of the Placement Agent with respect to securing any other financing on
behalf of the Company. The Placement Agent shall have no authority to bind the Company with respect to any prospective offer to
purchase Securities and the Company shall have the sole right to accept offers to purchase Securities and may reject any such offer,
in whole or in part.


 


The Company acknowledges that Sunrise
may rely on other broker-dealers who are members of the Financial Investment Regulatory Authority to participate in placing a portion
of the Placement provided that such other broker-dealers (including any co-placement) are acceptable to the Company and Sunrise
and that the Company and Sunrise consent to such participation in advance and in writing.


 


Section 1. Compensation and Other
Fees. As compensation for the services provided by the Placement Agent hereunder, the Company agrees to pay to the Placement
Agent:


 


(i) 7.00% times the aggregate gross proceeds
raised in the Placement; and


 


(ii) warrants, exercisable for a period
of five years from the effective date of the registration statement, which shall entitle the Placement Agent to purchase a number
of shares of Common Stock equal to an aggregate of 5% of the shares of Common Stock sold by the Placement Agent in the Placement.
The warrants will have an exercise price equal to 125% of the offering price of the shares sold in the Placement.


 


The warrants will be subject to a lock-up
restriction for 180 days pursuant to FINRA Rule 5110(g). The warrants shall be sold to the Placement Agent for $100.


 


Section 2. Registration Statement
and Prospectus. The Company represents and warrants to, and agrees with, the Placement Agent that:


 



    	 



    	 



    

 


(a) The Company has prepared and filed
with the Securities and Exchange Commission (the “Commission”) a registration statement, on Form S-1
(Registration File No. 333-178837) (the "Registration Statement"), under the Securities Act of 1933, as
amended (the “Securities Act”), which became effective on February 13, 2012, for the registration under
the Securities Act of the Shares. “Preliminary Prospectus” refers to any preliminary prospectus related
to the Registration Statement, including any prospectus that is included in the Registration Statement immediately prior to the
effectiveness of the Registration Statement. The form of the final prospectus dated the effective date of the Registration Statement
(or, if applicable, the form of final prospectus containing information permitted to be omitted at the time of effectiveness by
Rule 430A of the Securities Act filed with the Commission pursuant to Rule 424 of the Securities Act), is hereinafter called the
“Prospectus.” For purposes of this Agreement, “Time of Sale”,
as used in the Act, means 9:00 a.m., New York City time, on the date of this Agreement. Prior to the Time of Sale, the Company
prepared a Preliminary Prospectus, dated February 13, 2012, and a supplement to such Preliminary Prospectus, dated February 29,
2012, for distribution by the Placement Agent (collectively, the “Statutory Prospectus”).


 


Any reference in this Agreement to
the Registration Statement shall be deemed to refer to and include the appendixes to the Registration Statement and the documents
incorporated by reference therein (the “Incorporated Documents”) including those which were filed under
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on or before the date of this Agreement.
Any reference in this Agreement to the terms “amend,” “amendment” or “supplement” with respect
to the Registration Statement shall be deemed to refer to and include the filing of any document under the Exchange Act after the
date of this Agreement deemed to be incorporated therein by reference. All references in this Agreement to financial statements
and schedules and other information which is “contained,” “included,” “described,” “referenced,”
“set forth” or “stated” in the Registration Statement (and all other references of like import) shall be
deemed to mean and include all such financial statements and schedules and other information which is or is deemed to be incorporated
by reference in the Registration Statement.


 


No stop order suspending the effectiveness
of the Registration Statement has been issued, and no proceeding for any such purpose is pending or has been initiated or, to the
Company’s knowledge, is threatened by the Commission. For purposes of this Agreement, the term “knowledge”
as used in this Agreement with respect to the Company shall mean actual knowledge of the Company’s officers and directors
after due and reasonable inquiry.


 


(b) The Registration Statement (and
any further documents to be filed with the Commission in connection with the Placement) contains or will contain, as applicable,
all exhibits and schedules as required by the Securities Act and the rules and regulations of the Commission promulgated thereunder
(the “Rules and Regulations”). The Registration Statement and any post-effective amendment thereto, at
the time it became effective, complied in all material respects with the Securities Act and the applicable Rules and Regulations
and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not misleading. As of its date,
the Closing Date (as defined in Section 4), the Prospectus (together with any supplement thereto) did not and will not include
any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. At the Time of Sale, the Statutory Prospectus did not
include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. No post-effective amendment to the Registration Statement
reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental
change in the information set forth therein is required to be filed with the Commission. There are no documents required to be
filed with the Commission in connection with the transaction contemplated hereby that (x) have not been filed as required pursuant
to the Securities Act or (y) will not be filed within the requisite time period. There are no contracts or other documents required
to be described in the Registration Statement, or to be filed as exhibits or schedules to the Registration Statement, which have
not been described or filed as required.


 


(c) The Company had a reasonable basis
for, and made in good faith, each “forward-looking statement” (within the meaning of Section 27A of the Securities
Act or Section 21E of the Exchange Act) contained in the Registration Statement.


 


(d) All statistical or market-related
data included in the Statutory Prospectus and the Prospectus are based on or derived from sources that the Company reasonably believes
to be reliable and accurate, and, to the extent necessary, the Company has obtained the written consent to the use of such data
from such sources.


 



    	2



    	 



    

 


(e) The Company has delivered, or will
as promptly as practicable deliver, to the Placement Agent complete conformed copies of the Registration Statement and of each
consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies of the Registration Statement
(without exhibits), any Preliminary Prospectus and the Prospectus, as amended or supplemented, in such quantities and at such places
as the Placement Agent reasonably requests. Neither the Company nor any of its directors and officers has distributed and none
of them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Securities
other than the Registration Statement, the Preliminary Prospectus or the Prospectus and any other materials permitted by the Securities
Act.


 


Section 3. Representations Warranties
and Certain Agreements. The Company represents and warrants to, and agrees with, the Placement Agent that:


 


(a) Organization and Qualification.
All of the direct and indirect “significant subsidiaries” (as defined in Rule 1-02(w) of Regulation S-X) (individually,
a “Subsidiary”) of the Company are set forth in Exhibit 21.1 of the Registration Statement. Except as
set forth in the Preliminary Prospectus and the Prospectus, the Company owns, directly or indirectly, all of the capital stock
or other equity interests of each Subsidiary free and clear of any “Liens” (which for purposes of this
Agreement shall mean a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction,
other than restrictions imposed by applicable securities laws). All the issued and outstanding shares of capital stock of each
Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or
purchase securities. The Company and each of the Subsidiaries is an entity validly existing and in good standing under the laws
of the jurisdiction of its incorporation or organization (as applicable), with the requisite power and authority to own and use
its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation
or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as
a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it
makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would
not have or reasonably be expected to result in (i) a material adverse effect on the legality, validity or enforceability of any
Transaction Document, (ii) a material adverse effect on the results of operations, assets, business or condition (financial or
otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability
to perform in any material respect its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”) and, to the Company’s knowledge, no “Proceeding” (which for purposes
of this Agreement shall mean any action, claim, suit, investigation or proceeding (including, without limitation, an investigation
or partial proceeding, such as a deposition), whether commenced or threatened) has been instituted in any such jurisdiction revoking,
limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.


 


(b) Authorization; Enforcement.
The Company has the requisite corporate power and authority to enter into each of the Transaction Documents, to consummate the
transactions contemplated hereby and thereby, and otherwise to carry out its obligations hereunder and thereunder. The execution
and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated thereby
have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company,
its board of directors or its shareholders in connection therewith other than in connection with the Required Approvals (as defined
in Section 3(d) below). Each Transaction Document has been (or upon delivery will have been) duly executed by the Company and,
when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company
enforceable against the Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by
laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (iii) as enforceability
of any indemnification or contribution provision may be limited under the foreign, federal and state securities laws.


 


(c) No Conflicts. The execution,
delivery and performance of the Transaction Documents by the Company, the issuance and sale of the Securities and the consummation
by the Company of the other transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision
of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter
documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a
default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give
to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding
to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or
affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order,
judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is
subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary
is bound or affected; except in the case of each of clauses (ii) and (iii), such as would not have or reasonably be expected to
result in a Material Adverse Effect.


 



    	3



    	 



    

 


(d) Filings, Consents and Approvals.
The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other governmental authority or other “Person”
(defined as an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited
liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind)) in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than such filings as are required
to be made under applicable federal and state securities laws, and rules and regulations promulgated by FINRA (collectively, the
“Required Approvals”), all of which will be made in a timely manner to the extent such filings are required
or desirable to be made by the Company, with the exception of filings with FINRA, which the parties have agreed will be made by
Sunrise.


 


(e) Issuance of the Securities;
Registration. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The
Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to the
Transaction Documents. The issuance by the Company of the Securities has been registered under the Securities Act and all of such
shares are freely transferable and tradable by the Purchasers without restriction (other than any restrictions arising solely from
an act or omission of a Purchaser). The Securities are being issued pursuant to the Registration Statement and the issuance of
the Securities has been registered by the Company under the Securities Act. The Registration Statement was declared effective on
February 13, 2012 and is available for the issuance of the Securities thereunder and the Company has not received any notice that
the Commission has issued or intends to issue a stop-order with respect to the Registration Statement or that the Commission otherwise
has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, or intends or has
threatened in writing to do so. The Purchasers will have good and marketable title to the Shares upon receipt of such Shares, and
such securities will be freely tradable on the “Trading Market” (which, for purposes of this Agreement
shall mean the Over-the-Counter Bulletin Board).


 


(f) Capitalization. The capitalization
of the Company is as set forth in the “Actual” column in the table contained in the heading “Capitalization”
in the Statutory Prospectus and the Prospectus. No Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as disclosed in the Statutory
Prospectus and the Prospectus or pursuant to equity compensation plans or agreements filed as exhibits to the Registration Statement,
there are no outstanding options, warrants, script rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to
subscribe for or acquire, any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company
or any Subsidiary is or may become bound to issue additional shares of Common Stock. The issuance and sale of the Securities will
not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Purchasers and Sunrise)
and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price
under such securities. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully
paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval
or authorization of any shareholder, the Board of Directors of the Company or others is required for the issuance and sale of the
Securities. There are no shareholders agreements, voting agreements or other similar agreements with respect to the Company’s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s
shareholders.


 



    	4



    	 



    

 


(g) SEC Reports; Financial Statements.
From and after the date on which the Company initially filed its “Form 10 information” (as defined in Rule 144 of the
Securities Act), the Company has complied in all material respects with requirements to file reports, schedules, forms, statements
and other documents under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the “SEC Reports”). From and after the date on which the Company initially filed its “Form 10
information”, the Company has filed on a timely basis, or has received a valid extension of such time of filing and has filed
any such reports prior to the expiration of any such extension, all reports, schedules, forms, statements and other documents required
to be filed by it under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Exchange Act and the rules and
regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company
included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance
with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company
and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods
then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.


 


(h) Material Changes; Undisclosed
Events, Liabilities or Developments. Since the date of the latest audited financial statements included in the
Statutory Prospectus and the Prospectus, except as specifically disclosed in the Statutory Prospectus and the Prospectus (including
in any interim financial information included in the Statutory Prospectus and the Prospectus), (i) there has been no event, occurrence
or development that has had or that would reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not
incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary
course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial
statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the Company has not altered
its method of accounting, and (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock. Except
for the issuance of the Securities contemplated by this Agreement, no event, liability or development has occurred or exists with
respect to the Company or its Subsidiaries or their respective business, properties, operations or financial condition, that would
be required to be disclosed by the Company under applicable securities laws at the time this representation is made that has not
been publicly disclosed prior to the date that this representation is made.


 


(i) Litigation. Except as disclosed
in the Statutory Prospectus and the Prospectus, there is no action, suit, inquiry, notice of violation, Proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective
properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county,
local or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality,
validity or enforceability of any of the Transaction Documents or the Securities, or (ii) would reasonably be expected to result
in a Material Adverse Effect. Except as disclosed to the Placement Agent in writing, neither the Company nor any Subsidiary, nor,
to the Company’s knowledge, any director or officer thereof, is or has been the subject of any Action involving a claim of
violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and
to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company
or, to the Company’s knowledge, any director or officer of the Company. The Commission has not issued any stop order or other
order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act
or the Securities Act.


 



    	5



    	 



    

 


(j) Employment and Labor Relations.
No executive officer, to the knowledge of the Company, is, or is now expected to be, in violation of any material term of any employment
contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract
or agreement or any restrictive covenant, and, to the Company’s knowledge, the continued employment of each such executive
officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters.
The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating
to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be
in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. No material
labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company which
would reasonably be expected to result in a Material Adverse Effect.


 


(k) Compliance. Neither the
Company nor any Subsidiary (i) is in default under or in violation of (and no event has occurred that has not been waived that,
with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether
or not such default or violation has been waived), (ii) is in violation of any order of any court, arbitrator or governmental body,
or (iii) is or has been in violation of, or has received any notice of violation relating to, any statute, rule or regulation of
any governmental authority, in each case which would reasonably be expected to result in a Material Adverse Effect.


 


(l) Regulatory Permits. The
Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local
or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where
the failure to possess such permits would not have or reasonably be expected to result in a Material Adverse Effect (“Material
Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation
or modification of any Material Permit, except where such potential revocation or modification would not reasonably be expected
to result in a Material Adverse Effect.


 


(m) Title to Assets. The Company
and the Subsidiaries have good and marketable title in fee simple to all real property owned by them that is material to the business
of the Company and the Subsidiaries and good and marketable title in all personal property owned by them that is material to the
business of the Company and the Subsidiaries, in each case free and clear of all Liens, except as set forth in the Statutory Prospectus
and the Prosepctus and except for Liens created under license or collaboration agreements relating to the Company’s products
or Intellectual Property Rights and Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and the Subsidiaries and Liens for the payment of federal,
state or other taxes, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held
under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases of which the Company
and the Subsidiaries are in compliance with the provisions thereof, except where such non-compliance would not have a Material
Adverse Effect.


 


(n) Patents and Trademarks.
The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other similar intellectual property rights necessary
or material for use in connection with their respective businesses as described in the Statutory Prospectus and the Prospectus
(collectively, the “Intellectual Property Rights”). To the knowledge of the Company, all such Intellectual
Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights
of the Company which would reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company, none of the
Intellectual Property Rights used by the Company or any Subsidiary violates or infringes upon the rights of any Person. The Company
and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their
intellectual properties, except where failure to do so would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect.


 


(o) Insurance. The Company and
the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts
as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage in an amount prudent and customary in the businesses in which the Company and the
Subsidiaries are engaged. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its
existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary
to continue its business at a cost that would not have a Material Adverse Effect.


 



    	6



    	 



    

 


(p) Transactions With Officers.
Except as set forth in the Statutory Prospectus and the Prospectus, none of the officers or directors of the Company is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or
personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge
of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee or partner, in each case in excess of $120,000, other than for (i) payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including but not limited
to stock option agreements under any stock option or other equity incentive plan of the Company.


 


(q) Internal Accounting Controls;
Sarbanes-Oxley; Disclosure Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the
recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences.


 


The Company is in material compliance
with all provisions of the Sarbanes-Oxley Act of 2002 which are applicable to it as of the date of this Agreement. The Company
maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Exchange Act) that are effective
in ensuring that information required to be disclosed by the Company in the reports that it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Commission,
including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company
in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management,
including its principal executive officer or officers and its principal financial officer or officers, as appropriate, to allow
timely decisions regarding required disclosure.


 


(r) Certain Fees. Except as
otherwise provided in this Agreement or as set forth in Statutory Prospectus and the Prospectus, no brokerage or finder’s
fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent,
investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents, and there are
no other arrangements, agreements, understandings, payments or issuances with respect to the Company that may affect the Placement
Agent’s compensation, as determined by FINRA. The Company has not made any direct or indirect payments (in cash, securities
or otherwise) to (i) any person, as a finder’s fee, investing fee or otherwise, in consideration of such person raising capital
for the Company or introducing to the Company persons who provided capital to the Company, (ii) any FINRA member, or (iii) any
person or entity that has any direct or indirect affiliation or association with any FINRA member. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section 3(r) that may be due in connection with the transactions contemplated by the Transaction Documents. Other than
Sunrise, no person has the right to act as a placement agent, underwriter or as a financial advisor in connection with the sale
of the Securities contemplated hereby.


 


(s) Investment Company. The
Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be or be an Affiliate
of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.


 


(t) Registration Rights. No
Person has any right to cause the Company to effect the registration under the Securities Act of any securities of the Company.


 


(u) Tax Status. Except for matters
that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company
and each Subsidiary has filed all necessary federal, state and foreign income and franchise tax returns and has paid or accrued
all taxes shown as due thereon, and the Company has no knowledge of a tax deficiency which has been asserted or threatened against
the Company or any Subsidiary.


 



    	7



    	 



    

 


(v) Foreign Corrupt Practices; OFAC.
Neither the Company, nor to the knowledge of the Company, any agent or other person acting on behalf of the Company, has (i) directly
or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or
domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any
foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by
the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated
in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended.


 


Neither the Company nor any of its
Subsidiaries nor, to the Company’s knowledge, any director, officer, employee, representative, agent or affiliate of the
Company or any of its Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control
of the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds
of the Placement contemplated hereby, or lend, contribute or otherwise make available such proceeds to any person or entity, for
the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC.


 


(w) Accountants. The Company’s
accountants are Gregory & Associates, LLC, independent registered public accountants. To the knowledge of the Company, such
accountants are a registered public accounting firm as required by the Securities Act.


 


(x) Regulation M Compliance.
The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed
to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or
resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the
Securities or (iii) paid or agreed to pay to any person any compensation for soliciting another to purchase any other securities
of the Company other than, in the case of clauses (ii) and (iii), services under this Agreement.


 


(y) FINRA Affiliations. There
are no affiliations with any FINRA member firm among the Company’s officers, directors or, to the knowledge of the Company,
any five percent (5%) or greater shareholder of the Company. The Company will advise Sunrise and its counsel if it becomes aware
that any officer, director or shareholder of the Company or its subsidiaries is or becomes an affiliate or associated person of
a FINRA member participating in the Placement.


 


(z) Business Relationships.
No supplier, customer, distributor or sales agent of the Company has notified the Company that it intends to discontinue or decrease
the rate of business done with the Company, except where such decrease is not reasonably likely to result in a Material Adverse
Effect or has been set forth in the SEC Reports.


 


(aa) Other Filings with the Commission.
The Company shall have prepared and filed with the Commission a Current Report on Form 8-K with respect to the Placement, including
as an exhibit thereto this Agreement, within the timeframe required for the filing of such form by the Commission.


 


Section 4. Closing and Settlement.
Subject to the terms and conditions hereof, payment of the purchase price for, and delivery of, the Securities shall be made
at one or more closings (each a “Closing” and the date on which each Closing occurs, a “Closing
Date”) at the offices of Sunrise Securities Corp. (or at such other place as shall be agreed upon by Sunrise and
the Company), the first such Closing to take place at 10:00 a.m., New York City time, on March 7, 2012 (unless another time shall
be agreed to by Sunrise and the Company). On each Closing, (i) the Company will deliver, or cause to
be delivered, to the Placement Agent by authorizing the release of the Shares to the Purchasers via DWAC delivery prior to the
release of payment for such Shares, and (ii) each Purchaser will deliver, or cause to be delivered, to the Company, the aggregate
purchase price for the Shares no later than one business day after receipt of the Purchaser’s Shares.


 



    	8



    	 



    

 


Section 5. Restriction on Issuances.
The Company hereby agrees that, without the prior written consent of the Placement Agent, it will not, during the period ending
180 days after the date hereof (“Lock-Up Period”), (i) offer, pledge, issue, sell, contract to sell,
purchase, contract to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or
any securities convertible into or exercisable or exchangeable for Common Stock; or (ii) enter into any swap or other arrangement
that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any
such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in
cash or otherwise; or (iii) file any registration statement with the Commission relating to the offering of any shares of Common
Stock or any securities convertible into or exercisable or exchangeable for Common Stock. The restrictions contained in the preceding
sentence shall not apply to (1) the Securities to be sold hereunder, (2) the issuance of Common Stock upon the exercise of options
or warrants disclosed as outstanding (or to be outstanding in connection with the Placement) in the Preliminary Prospectus and
the Prospectus, (3) the issuance of Common Stock, stock options, stock appreciation rights, restricted stock units, or other forms
of equity compensation as bona fide compensation to the Company’s officers, directors, employees, consultants or agents under
the Company’s equity incentive plans or employee stock purchase plan, under any agreements that the Company may have with
such persons, or as may be determined by the Compensation Committee of the Board of Directors, (4) the filing of a registration
statement or amendment to a registration statement on Form S-8, or (5) the issuance of shares of Common Stock in connection
with any strategic investment or alliance, joint venture or corporate partnership arrangement that may be entered into by the Company
that is valued at $10 million or more. Notwithstanding the foregoing, if (x) the Company issues an earnings release or material
news, or a material event relating to the Company occurs, during the last 17 days of the Lock-Up Period, or (y) prior to the expiration
of the Lock-Up Period, the Company announces that it will release earnings results during the 16-day period beginning on the last
day of the Lock-Up Period, the restrictions imposed by this clause shall continue to apply until the expiration of the 18-day period
beginning on the issuance of the earnings release or the occurrence of the material news or material event, unless the Placement
Agent waives such extension in writing. The Company’s officers, directors or, to the knowledge of the Company, any five percent
(5%) or greater shareholder of the Company shall each sign a Lock-Up Agreement in the form of Addendum A.


 


Section 6. Indemnification.
The Company agrees to the indemnification and other agreements set forth in the indemnification provisions attached hereto
as Addendum B (“Indemnification Provisions”), the provisions of which are incorporated
herein by reference and shall survive the termination or expiration of this Agreement.


 


Section 7. Engagement Term.
Unless terminated pursuant to Section 14, the Placement Agent’s engagement hereunder will be for the period of ten (10)
days or, if longer, until the occurrence of a closing of a sale of the Securities under one or more subscription agreements entered
into by the Company and one or more Purchasers during such ten (10)-day term. Notwithstanding anything to the contrary contained
herein, the provisions concerning confidentiality, indemnification, contribution and the Company’s obligations to reimburse
expenses contained herein and the Company’s obligations contained in the Indemnification Provisions will survive any expiration
or termination of this Agreement.


 


Section 8. Placement Agent
Information. The Company agrees that any information or advice rendered by the Placement Agent in connection with this engagement
is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required by law,
the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent’s
prior written consent.


 


Section 9. No Fiduciary Relationship.
The Company acknowledges and agrees that: (a) Sunrise has been retained solely to act as placement agent in connection with
the sale of the Securities and that no fiduciary, advisory or agency relationship between the Company and Sunrise has been created
in respect of any of the transactions contemplated by this Agreement, irrespective of whether Sunrise has advised or is advising
the Company on other matters; (b) the price and other terms of the Securities set forth in this Agreement were established by Sunrise
and the Purchasers following discussions and arms-length negotiations and the Company is capable of evaluating and understanding
and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement; (c) it has been
advised that Sunrise and its affiliates are engaged in a broad range of transactions that may involve interests that differ from
those of the Company and that Sunrise has no obligation to disclose such interest and transactions to the Company by virtue of
any fiduciary, advisory or agency relationship; (d) it has been advised that Sunrise is acting, in respect of the transactions
contemplated by this Agreement, solely for the benefit of Sunrise, and not on behalf of the Company.


 


Section 10. No Limitations. Nothing
in this Agreement shall be construed to limit the ability of Sunrise or its affiliates to (a) trade in the Company’s or any
other company’s securities or publish research on the Company or any other company, subject to applicable law, or (b) pursue
or engage in investment banking, financial advisory or other business relationships with entities that may be engaged in or contemplate
engaging in, or acquiring or disposing of, businesses that are similar to or competitive with the business of the Company.


 



    	9



    	 



    

 


Section 11. Persons Entitled to Benefit
of Agreement. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors
and assigns and, solely in respect of Section 6 to this Agreement, the Indemnified Persons (as defined in Addendum B)
pursuant to Section 6. In addition, the investors who purchase Securities pursuant to the subscription agreements shall be entitled
to rely on the representations, warranties, covenants and agreements of the Company contained in this Agreement and shall be third
party beneficiaries thereof. Except as indicated above, nothing in this Agreement is intended or shall be construed to give to
any other person, firm or corporation any legal or equitable remedy or claim under or in respect of this Agreement or any provision
herein contained.


 


Section 12. Conditions to Closing.
The obligations of the Placement Agent and the Purchasers, and the closing of the sale of the Securities contemplated hereby
are subject to the following conditions:


 


(a) Representations and Warranties.
The representations and warranties of the Company contained herein shall be true and correct in all material respects as of the
date when made and as of the Closing Date, as though made on and as of the Closing Date, except for representations and warranties
that speak as of a specific date which shall be true and correct in all material respects as of such date.


 


(b) Performance. The Company
shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by
the Transaction Documents to be performed, satisfied or complied with by it at or prior to the closing of the Placement.


 


(c) No FINRA Objection. FINRA
shall have raised no objection to the fairness and reasonableness of the placement agency terms and arrangements.


 


(d) Contents of Statutory Prospectus
and Prospectus. The Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date
that the Statutory Prospectus and the Prospectus or any amendment or supplement thereto contains an untrue statement of a fact
which, in the opinion of counsel for the Placement Agent, is material or omits to state any fact which, in the opinion of such
counsel, is material and is required to be stated therein or is necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading.


 


(e) Authorizations. All corporate
proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement,
the Securities, the Registration Statement and all other legal matters relating to this Agreement and the transactions contemplated
hereby shall be reasonably satisfactory in all material respects to counsel for the Placement Agent, and the Company shall have
furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters.


 


(f) Opinion of Counsel to the Company.
The Placement Agent shall have received from counsel to the Company such counsel’s written opinion, addressed to the Placement
Agent and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement Agent.


 


(g) Letter from Auditors. The
Placement Agent shall have received a letter from Gregory & Associates, LLC on the date hereof and on the applicable Closing
Date addressed to the Placement Agent, confirming that they are independent public accountants within the meaning of the Securities
Act and are in compliance with the applicable requirements relating to the qualifications of accountants under Rule 2-01 of Regulation
S X of the Commission, and confirming, as of the date of each such letter, the conclusions and findings of said firm with respect
to the financial information, including any financial information contained in reports filed by the Company with the Commission
pursuant to the reporting requirements of the Exchange Act, and other matters required by the Placement Agent.


 



    	10



    	 



    

 


(h) Absence of Material Change.
Neither the Company nor any of its Subsidiaries shall have sustained since the date of the latest audited financial statements
included in the Statutory Prospectus and the Prospectus, (i) any material loss or interference with its business from fire, explosion,
flood, terrorist act or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental
action, order or decree, otherwise than as set forth in or contemplated by the Statutory Prospectus and the Prospectus, and (ii)
since such date there shall not have been any material change in the capital stock or material increase in the long-term debt of
the Company or any of its Subsidiaries or any material change, or any development involving a prospective material change, in or
affecting the business, general affairs, management, financial position, shareholders’ equity, results of operations or prospects
of the Company and its Subsidiaries, otherwise than as included in, or contemplated by, the Statutory Prospectus and the Prospectus,
the effect of which, in any such case described in clause (i) or (ii), is, in the judgment of the Placement Agent, so material
and adverse as to make it impracticable or inadvisable to proceed with the sale or delivery of the Securities on the terms and
in the manner contemplated by the Registration Statement.


 


(i) Continued Registration; Listing
on Trading Market. The Common Stock is registered under the Exchange Act and, as of the Closing Date, the Shares shall be quoted
and authorized for trading on the Company’s Trading Market, and satisfactory evidence of such actions shall have been provided
to the Placement Agent. The Company shall have taken no action designed to, or likely to have the effect of terminating the registration
of the Common Stock under the Exchange Act or suspending from trading the Common Stock from the Company’s Trading Market,
nor has the Company received any information suggesting that the Commission or the Company’s Trading Market is contemplating
terminating such registration or listing.


 


(j) Absence of Certain Events.
Subsequent to the execution and delivery of this Agreement, there shall not have occurred any of the following: (i) trading in
securities generally on any Trading Market or in the over-the-counter market, or trading in any securities of the Company on any
Trading Market or in the over-the-counter market, shall have been suspended or minimum or maximum prices or maximum ranges for
prices shall have been established on any such exchange or such market by the Commission, by such exchange or by any other regulatory
body or governmental authority having jurisdiction, (ii) a banking moratorium shall have been declared by federal or state authorities
or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States,
(iii) the United States shall have become engaged in hostilities in which it is not currently engaged, the subject of an act of
terrorism, there shall have been an escalation in hostilities involving the United States, or there shall have been a declaration
of a national emergency or war by the United States, or (iv) there shall have occurred any other calamity or crisis or any change
in general economic, political or financial conditions in the United States or elsewhere, if the effect of any such event in clause
(iii) or (iv) makes it, in the sole judgment of the Placement Agent, impracticable or inadvisable to proceed with the sale or delivery
of the Securities on the terms and in the manner contemplated by the Registration Statement.


 


(k) Prevention of Issuance.
No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or result in a Material Adverse
Effect; and no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction
shall have been issued as of the Closing Date which would prevent the issuance or sale of the Securities or result in Material
Adverse Effect.


 


(l) [RESERVED].


 


(m) Subscription Agreements.
The Company shall have entered into subscription agreements with each of the Purchasers and such agreements shall be in full force
and effect on the Closing Date.


 


(n) Officers’ Certificate.
On the Closing Date, there shall have been furnished to the Placement Agent, a certificate, dated such Closing Date and addressed
to the Placement Agent, signed by the principal executive officer and by the principal financial and accounting officer of the
Company, certifying to the fulfillment of the conditions specified in Section 12(a), (b), (e) and (h) (other than, in respect clause
(h), the judgment of the Placement Agent). Any certificate signed by any officer of the Company shall be deemed a representation
and warranty by the Company to the Placement Agent as to the matters covered thereby.


 


(o) Secretary’s Certificate.
On the Closing Date, the Company shall have furnished to the Placement Agent a certificate of the Secretary of the Company (the
“Secretary’s Certificate”), dated as of the Closing Date, (i) certifying the resolutions adopted
by the Board of Directors of the Company approving the transactions contemplated by this Agreement and the other Transaction Documents
and the issuance of the Securities, (ii) certifying the current versions of the articles of incorporation, as amended and by-laws,
as amended, of the Company and (iii) certifying as to the signatures and authority of persons signing the Transaction Documents
and related documents on behalf of the Company.


 



    	11



    	 



    

 


(p) Prior to the Closing Date, the
Company shall have furnished to the Placement Agent such further information, certificates and documents as the Placement Agent
may reasonably request.


 


All opinions, letters, evidence and
certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only
if they are in form and substance reasonably satisfactory to counsel for the Placement Agent.


 


Section 13. Notices. All notices or other communications
required or permitted to be provided hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery
to the party to be notified, (b) when sent by confirmed e-mail, telex or facsimile if sent during normal business hours of the
recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified mail, return
receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier, specifying next
day delivery, with written verification of receipt. The address for such notices and communications shall be as set forth on the
signature pages hereto or at such other address as such recipient has designated by two days advance written notice to the other
parties hereto.


 


Section 14. Termination of this Agreement.


 


(a) The Placement Agent shall have
the right to terminate this Agreement (and the obligations of the Purchasers under subscription agreements entered into with the
Company) by giving notice as hereinafter specified at any time at or prior to the Closing Date, without liability on the part of
the Placement Agent to the Company, if (i) prior to delivery and payment for the Securities (A) trading in securities generally
shall have been suspended on or by any Trading Market, (B) trading in the Common Stock of the Company shall have been suspended
on any exchange, in the over-the-counter market or by the Commission, (C) a general moratorium on commercial banking activities
shall have been declared by federal or state authorities or a material disruption shall have occurred in commercial banking or
securities settlement or clearance services in the United States, (D) there shall have occurred any outbreak or material escalation
of hostilities or acts of terrorism involving the United States or there shall have been a declaration by the United States of
a national emergency or war, (E) there shall have occurred any other calamity or crisis or any material change in general economic,
political or financial conditions in the United States or elsewhere, if the effect of any such event specified in clause (D) or
(E), in the judgment of the Placement Agent, is material and adverse and makes it impractical or inadvisable to proceed with the
completion of the sale of and payment for the Securities on the Closing Date on the terms and in the manner contemplated by this
Agreement, the Statutory Prospectus and the Prospectus, (ii) since the time of execution of this Agreement, there has been any
Material Adverse Change or the Company or any Subsidiary shall have sustained a loss or interference with its business by strike,
fire, flood, earthquake, accident or other calamity, whether or not covered by insurance, in each case which is not described in
the Statutory Prospectus and the Prospectus, and is of such character that in the judgment of the Placement Agent would, individually
or in the aggregate, result in a Material Adverse Change and which would, in the judgment of the Placement Agent, make it impracticable
or inadvisable to proceed with the offering or the delivery of the Securities on the terms and in the manner contemplated in this
Agreement, the Statutory Prospectus and the Prospectus, (iii) the Company shall have failed, refused or been unable to comply with
the terms or perform any agreement or obligation of this Agreement or any subscription agreement entered into with Purchasers,
other than by reason of a default by the Placement Agent, or (iv) any condition of the Placement Agent’s obligations hereunder
is not fulfilled. Any such termination shall be without liability of any party to any other party, except that the Company will
reimburse the Placement Agent for all of their out-of-pocket expenses actually incurred by them in connection with the Placement
and that the provisions of Section 6, and Section 15 hereof shall at all times be effective notwithstanding such termination.


 


(b) If the Placement Agent elects to
terminate this Agreement as provided in this Section 14, the Company shall be notified promptly by the Placement Agent by telephone,
confirmed by letter.


 


Section 15. Governing Law.
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT
TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
If either party shall commence a Proceeding to endorse any provisions of a Transaction Document, then the prevailing party in such
Proceeding shall be reimbursed by the other party for its reasonable attorney’s fees and other reasonable costs and expenses
incurred with the investigation, preparation and prosecution of such Proceeding.


 



    	12



    	 



    

 


Section 16. Entire Agreement;
Miscellaneous. This Agreement (including the attached Indemnification Provisions) embodies the entire agreement and understanding
between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof. If any
provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such
provision in any other respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement
may not be amended or otherwise modified or waived except by an instrument in writing signed by each of the Placement Agent and
the Company. The representations, warranties, agreements and covenants contained herein shall survive the closing of the Placement
and delivery of the Securities. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their
respective successors and permitted assigns. This Agreement may be executed in two or more counterparts, all of which when taken
together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party
and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any
signature is delivered by facsimile transmission or a .pdf format file, such signature shall create a valid and binding obligation
of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf
signature page were an original thereof.


 


Section 17. Construction. The
parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the event an ambiguity or question
of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties and no presumption or
burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement.


 


[Signature page follows]


 



    	13



    	 



    

 


Please confirm that the foregoing correctly
sets forth our agreement by signing and returning to the Placement Agent the enclosed copy of this Agreement.


 


	 	LIQTECH INTERNATIONAL, INC.
	 	 	 	 
	 	By:	/s/ Lasse Andreassen
	 	 	 	 
	 	 	Name:	Lasse Andreassen
	 	 	 	 
	 	 	Title:	Chief Executive Officer
	 	 	 	 
	 	Address for Notice:
	 	LiqTech International, Inc.
	 	c/o LiqTech North America Inc.
	 	1804 Buerkle Road
	 	White Bear Lake, MN 55110
	 	Attention: Soren Degn
	 	Facsimile: (651) 773-5850
	 	 
	 	With a copy to:
	 	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
	 	The Chrysler Center
	 	666 Third Avenue
	 	New York, NY 10017
	 	Attention: Kenneth R. Koch and Jeffrey P. Schultz 
	 	Facsimile: (212) 983-3115
	 	 
	 	Accepted and agreed to as of the date first written above:
	 	 
	 	SUNRISE SECURITIES CORP.
	 	 	 	 
	 	By:	/s/ Nathan Low
	 	 	 	 
	 	 	Name:	Nathan Low
	 	 	 	 
	 	 	Title:	President
	 	 	 	 
	 	Address for Notice:
	 	Sunrise Securities Corp.
	 	600 Lexington Avenue, 23rd Floor
	 	New York, NY 10022
	 	Facsimile:
	 	 
	 	With a copy to:
	 	Richardson & Patel LLP
	 	750 Third Avenue
	 	New York, NY 10017
	 	Attention: David Feldman
	 	Facsimile: (917) 591-6898


 



    	 



    	 



    

 


ADDENDUM A


 


Form of Lock-Up Agreement


Sunrise Securities Corp.


600 Lexington Avenue, 23rd Floor


New York, NY 10022


 


Re: LiqTech International, Inc.
Public Offering of Common Stock


 


Dear Sirs:


 


In order to induce
Sunrise Securities Corp. (“Sunrise”) to enter in to a certain Placement Agency Agreement with LiqTech International,
Inc., a Nevada corporation (the “Company”), with respect to the public offering of shares of the Company’s
Common Stock, par value $0.001 per share (“Common Stock”), the undersigned hereby agrees that for a period (the
“lock-up period”) of 180 days following the date of the final registration statement filed by the Company with
the Securities and Exchange Commission in connection with such public offering (the “Registration Statement”),
the undersigned will not, without the prior written consent of the Representatives, directly or indirectly, (i) offer, sell, assign,
transfer, pledge, contract to sell, or otherwise dispose of, any shares of Common Stock or securities convertible into or exercisable
or exchangeable for Common Stock (including, without limitation, shares of Common Stock or any such securities which may be deemed
to be beneficially owned by the undersigned in accordance with the rules and regulations promulgated under the Securities Act of
1933, as the same may be amended or supplemented from time to time (such shares or securities, the “Beneficially Owned
Shares”)), (ii) enter into any swap, hedge or other agreement or arrangement that transfers in whole or in part, the
economic risk of ownership of any Beneficially Owned Shares, Common Stock or securities convertible into or exercisable or exchangeable
for Common Stock, or (iii) engage in any short selling of any Beneficially Owned Shares, Common Stock or securities convertible
into or exercisable or exchangeable for Common Stock.


 


If (i) the Company
issues an earnings release or material news or a material event relating to the Company occurs during the last seventeen (17) days
of the lock-up period, or (ii) prior to the expiration of the lock-up period, the Company announces that it will release earnings
results during the sixteen (16)-day period beginning on the last day of the lock-up period, the restrictions imposed by this Agreement
shall continue to apply until the expiration of the eighteen (18)-day period beginning on the issuance of the earnings release
or the occurrence of the material news or material event.


 


Notwithstanding
the foregoing, the foregoing restrictions shall not in any event apply to transfers of shares of Common Stock or Beneficially Owned
Shares (i) as a bona fide gift or gifts or pledge, provided that the undersigned provides prior written notice of such gift
or gifts or pledge to the Representatives and the donee or donees or pledgee or pledgees (as the case may be) thereof agree to
be bound by the restrictions set forth herein, (ii) either during the undersigned’s lifetime or on death by will or intestacy
to the undersigned’s immediate family or to a trust, the beneficiaries of which are exclusively the undersigned and a member
or members of the undersigned’s immediate family, provided that the transferee thereof agrees to be bound by the restrictions
set forth herein, (iii) to the undersigned and/or any member of the immediate family of the undersigned from or by a grantor retained
(or like-kind) annuity trust which exists as of the date hereof and was established for the direct or indirect benefit of the undersigned
and/or any member of the immediate family of the undersigned pursuant to the terms of such trust, (iv) if the undersigned is a
corporation, partnership or other business entity (A) to another corporation, partnership or other business entity that is
an affiliate (as defined under Rule 12b-2 of the Exchange Act) of the undersigned or (B) any distribution or dividend
to equity holders of the undersigned as part of a distribution or dividend by the undersigned (including upon the liquidation and
dissolution of the undersigned pursuant to a plan of liquidation approved by the undersigned’s equity holders), or if
the undersigned is a trust, to a grantor or beneficiary of the trust, (v) in the event of a default under a pledge which exists
as of the date hereof as security for a margin or loan account pursuant to the terms of such account, (vi) pursuant to any 10b5-1
trading plans in effect as of the date of the Offering and (vii) with the prior written consent of the Representatives. Any permitted
transferee noted in (i), (ii), (iii) and (iv) above shall execute a duplicate form of this Lock-Up Agreement or execute an agreement,
reasonably satisfactory to the Representatives, pursuant to which each transferee shall agree to receive and hold such Common Stock
or Beneficially Owned Shares subject to the provisions hereof, and there shall be no further transfer except in accordance with
the provisions hereof. For the purposes of this paragraph, “immediate family” shall mean spouse, domestic partner,
lineal descendant (including adopted children), father, mother, brother or sister of the transferor. Furthermore, the undersigned
shall be permitted to exercise of options to purchase shares of Common Stock or receive shares of Common Stock upon the vesting
of equity awards and the related transfer of shares of Common Stock to the Company (i) deemed to occur upon the cashless exercise
of such options or (ii) for the primary purpose of paying the exercise price of such options or for paying taxes (including
estimated taxes) due as a result of the exercise of such options or as a result of the vesting of such shares of Common Stock under
such equity awards.


 



    	 



    	 



    

 


In addition, the
undersigned hereby waives, from the date hereof until the expiration of the 180 day period following the date of the Registration
Statement, any and all rights, if any, to request or demand registration pursuant to the Securities Act of 1933, as amended, of
any shares of Common Stock or securities convertible into or exercisable or exchangeable for Common Stock that are registered in
the name of the undersigned or that are Beneficially Owned Shares. In order to enable the aforesaid covenants to be enforced, the
undersigned hereby consents to the placing of legends and/or stop-transfer orders with the transfer agent of the Common Stock with
respect to any shares of Common Stock, securities convertible into or exercisable or exchangeable for Common Stock or Beneficially
Owned Shares.


 


	 	[Signatory]	 
	 	 	 	 
	 	By:	 	 
	 	 	 	 
	 	 	Name:	 
	 	 	 	 
	 	 	Title:	 


 



    	 



    	 



    

 


ADDENDUM B


 


Sunrise Securities Corp.


600 Lexington Avenue, 23rd Floor


New York, NY 10022


 


Ladies and Gentlemen:


 


1. In connection
with our engagement of Sunrise Securities Corp. (the “Placement Agent” or "Sunrise") as Placement Agent,
LiqTech International, Inc. (the "Company") agrees to indemnify and hold harmless Sunrise and each of the other Indemnified
Parties (as hereinafter defined) from and against any and all losses, claims, damages, obligations, penalties, judgments, awards,
liabilities, costs, expenses and disbursements, and any and all pending or threatened actions, suits, proceedings and investigations
in respect thereof and any and all legal and other costs, expenses and disbursements in giving testimony or furnishing documents
in response to a subpoena or otherwise (including, without limitation, the costs, expenses and disbursements, as and when incurred,
of investigating, preparing, pursuing or defending any such action, suit, proceeding or investigation (whether or not in connection
with litigation in which any Indemnified Party is a party (collectively, "Losses"), directly or indirectly, caused by,
relating to, based upon, arising out of, or in connection with, Sunrise's acting for the Company, including, without limitation,
any act or omission by Sunrise in connection with its acceptance of or the performance or non-performance of its obligations under
the Placement Agency Agreement, any material breach by the Company of any representation, warranty, covenant or agreement contained
in the Placement Agency Agreement (or in any instrument, document or agreement relating thereto), or the enforcement by Sunrise
of their rights under the Placement Agency Agreement or these indemnification provisions, except to the extent that any such Losses
are the result of a settlement by an Indemnified Party effected without the Company's prior written consent (not to be unreasonably
withheld) or are found in a final judgment by a court of competent jurisdiction (not subject to further appeal) to have resulted
primarily from the gross negligence or willful misconduct of any Indemnified Party. The Company also agrees that no Indemnified
Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in connection
with the engagement of Sunrise by the Company or for any other reason, except to the extent that any such liability is found in
a final judgment by a court of competent jurisdiction (not subject to further appeal) to have resulted primarily and directly from
such Indemnified Party's gross negligence or willful misconduct.


 


2. These indemnification
provisions shall extend to the following persons (collectively, the "Indemnified Parties"): Sunrise and any sub-placement
agent that the Company and Sunrise consent to in writing, their present and former affiliated entities, partners, employees, legal
counsel, agents and controlling persons (within the meaning of the federal securities laws), and the officers, directors, partners,
stockholders, members, managers, employees, legal counsel, agents and controlling persons of any of them. These indemnification
provisions shall be in addition to any liability which the Company may otherwise have to any Indemnified Party.


 


3. If any action,
suit, proceeding or investigation is commenced, as to which an Indemnified Party proposes to demand indemnification, it shall notify
the Company with reasonable promptness; provided, however, that any failure by an Indemnified Party to notify the
Company shall not relieve the Company from their respective obligations hereunder. The Company shall provide for the engagement
of one law firm reasonably acceptable to the Indemnified Parties to provide legal representation to the Indemnified Parties, and
the reasonable fees, expenses and disbursements of such counsel shall be borne by the Company; provided, however, that any Indemnified
Person may retain his or her own legal counsel if a conflict would exist with such first firm of legal counsel. Any such counsel
shall, to the extent consistent with its professional responsibilities, cooperate with the Company and any counsel designated by
the Company, as applicable. The Company shall be liable for any settlement of any claim against any Indemnified Party made with
the prior written consent of the Company (which consent shall not be unreasonably withheld or delayed). The Company shall not,
without the prior written consent of Sunrise, settle or compromise any claim, or permit a default or consent to the entry of any
judgment in respect thereof, unless such settlement, compromise or consent (a) includes, as an unconditional term thereof, the
giving by the claimant to all of the Indemnified Parties of an unconditional release from all liability in respect of such claim,
and (b) does not contain any factual or legal admission by or with respect to an Indemnified Party or an adverse statement with
respect to the character, professionalism, expertise or reputation of any Indemnified Party or any action or inaction of any Indemnified
Party.


 



    	 



    	 



    

 


4. In order to provide
for just and equitable contribution, if a claim for indemnification pursuant to these indemnification provisions is made but it
is found in a final judgment by a court of competent jurisdiction (not subject to further appeal) that such indemnification may
not be enforced in such case, even though the express provisions hereof provide for indemnification in such case, then the Company
shall contribute to the Losses to which any Indemnified Party may be subject (a) in accordance with the relative benefits received
by the Company and its respective stockholders, subsidiaries and affiliates, on the one hand, and the Indemnified Party, on the
other hand, and (b) if (and only if) the allocation provided in clause (a) of this sentence is not permitted by applicable law
or by any such court, in such proportion as to reflect not only the relative benefits, but also the relative fault of the Company,
on the one hand, and the Indemnified Party, on the other hand, in connection with the statements, acts or omissions which resulted
in such Losses as well as any relevant equitable considerations. No person found liable for a fraudulent misrepresentation shall
be entitled to contribution from any person who is not also found liable for such fraudulent misrepresentation. The relative benefits
received (or anticipated to be received) by the Company and its respective stockholders, subsidiaries and affiliates shall be deemed
to be equal to the aggregate consideration payable or receivable by such parties in connection with the transaction or transactions
to which the Placement Agency Agreement relates relative to the amount of fees actually received by Sunrise in connection with
such transaction or transactions. Notwithstanding the foregoing, in no event shall the amount contributed by all Indemnified Parties
exceed the amount of fees previously received by Sunrise pursuant to the Placement Agency Agreement.


 


5. Neither termination
nor completion of the engagement of Sunrise referred to above shall effect these indemnification provisions which shall remain
operative and in full force and effect and shall be in addition to any liability that the Company might otherwise have to any Indemnified
Party under the Placement Agency Agreement or otherwise. The indemnification provisions shall be binding upon the Company and its
respective successors and assigns and shall inure to the benefit of the Indemnified Parties and their respective successors, assigns,
heirs and personal representatives.


 


These Indemnification
Provisions may be executed in any number of counterparts, each of which shall be deemed an original but all of which when taken
together shall constitute one and the same instrument. Facsimile signatures shall be deemed originals for all purposes hereunder.


 


The provisions of this agreement shall
remain in full force and effect following the completion or termination of the Placement Agent’s engagement.


 


	 	LIQTECH INTERNATIONAL, INC.
	 	 	 	 	 
	 	By:	/s/ Soren Degn 	 
	 	 	 	 	 
	 	 	Name:	Soren Degn	 
	 	 	 	 	 
	 	 	Title:	Chief Financial Officer	 
	 	 	 	 	 
	Accepted and agreed to as of	SUNRISE SECURITIES CORP.	 
	the date first written above:	 	 
	 	 	 	 	 
	 	By:	/s/ Nathan Low 	 
	 	 	 	 	 
	 	 	Name:	Nathan Low	 
	 	 	 	 	 
	 	 	Title:	President